Skip to main content

Biolife Solutions Inc

BLFS
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0000834365

No open-market purchases or sales by Biolife Solutions Inc insiders were filed in the last 90 days; 216 institutions reported holding it in 13F filings for Q2 2026, worth $1.40B in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Biolife Solutions Inc changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of BLFS: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders19251870
Shares48.3M168.9K48.9M+852.9K (+1.8%)
Value$1.23B$4.31M$1.18B−$39.6M (−3.2%)

5 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Biolife Solutions Inc at the end of Q4 2025 but not at the end of Q3 2025.

Sold out (25)

Institutions that held Biolife Solutions Inc at the end of Q3 2025 and filed for Q4 2025 without it.

Not filed for Q4 2025 yet (5)

Institutions that held Biolife Solutions Inc at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BLFS in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Bard Financial Services, Inc.153,475$3.92M
Glenmede Investment Management, LP12,826$327.2K
Point72 (DIFC) Ltd1,326$33.8K
Point72 Europe (London) LLP882$22.5K
Point72 Asia (Singapore) Pte. Ltd.347$8.85K